4
Changes in Ownership
Kura Oncology, Inc. Filed Acc 0001193125-25-283564
Chief Commercial Officer sold 8,887 shares at $11.18 ($99,329)
- Chief Commercial Officer acquired 48,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Powl Brian T. · Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-13 | Grant or award : show line 1 in the form | +48,900 | 148,576 | D | ||
| 2025-11-14 | Sale : show line 2 in the form | −8,887 | $11.18 | $99,329 | 139,689 | D |
| Open-market sales · 8,887 sh · avg $11.18 · $99,329 | ||||||
Loading xslF345X05/ownership.xml…